Watch our CEO, Ryan Davies, chat with leaders and experts in the biotech industry about trends, insights as well as progress with CancerVAX
CancerVAX CEO Discusses Expanded Pipeline at UCLA
August 14, 2023 - Steven Jonas - UCLA
June 28 , 2023 - Lara Sullivan - Pyxis Oncology
June 16, 2023 - Michael Smith - KalVista Pharmaceuticals
May 24, 2023 - Raymond Vennare - Predictive Oncology Inc.
May 17, 2023 - Dr. Dinesh Patel - Xenocor, Inc.
Apr 20, 2023 - Stephen Diamond - LEXEO Therapeutics
Apr 12, 2023 - Dr. Satiro De Oliveira - UCLA
Mar 23, 2023 - Ryan looper - Curza
Mar 21, 2023 - Jonathan Lakey - XOStem, Inc
Mar 19, 2023 - Dr. David Bearss - Halia Therapeutics
Mar 15, 2023 - Todd Kinard - Curza
Mar 15, 2023 - Partnered with Jonsson Comprehensive Cancer Center
Mar 15, 2023 - Seeking Immunotherapy Solutions that Prevent Cancer
Unlike Any Other Industry - CancerVAX CEO Ryan Davies talks Biotech
Mar 15, 2023 - Biomedical Research without Traditional Overhead Costs at CancerVA
Keep up with our progress by subscribing to our email newsletter!
This Reg A+ offering is made available through StartEngine Primary, LLC, member FINRA/SIPC. This investment is speculative, illiquid, and involves a high degree of risk, including the possible loss of your entire investment. You should read the Selected Risks, the Offering Circular, and Sec Edgar Page before investing.